Johnson & Johnson's plans to sell its professional wound care business won't affect Raleigh-based Closure Medical Corp. Closure Medical, which has about 120 workers, became part of J&J's Ethicon subsidiary in 2005 after agreeing to a $370 million takeover. Closure produces
Dermabond and other surgical glues. Ethicon announced Tuesday that its unit that produces dressings for wounds is being acquired by a private equity firm, One Equity Partners, for an undisclosed price. But its wound closure business, which includes Closure, isn't part of that deal, said Ethicon spokeswoman Jackie Russo-Jankewicz.
In 2007 the Professional Wound Care business had annual sales of about $270 million but terms of the financial transaction have not been disclosed.
Brands included in the Professional Wound Care product portfolio include:
- PROMOGRAN® Matrix Wound Dressing;
- TIELLE® Hydropolymer Dressing;
- REGRANEX® (becaplermin) Gel 0.01%, a prescription treatment for lower extremity diabetic ulcers; and
- A portfolio of general wound care products.
